| Literature DB >> 30987663 |
Jieting Wang1, Junqiang Qiu2, Longyan Yi1, Zhaoran Hou1, Dan Benardot3,4, Wei Cao1.
Abstract
BACKGROUND: Past studies have found that sodium bicarbonate ingestion prior to exercise has a performance-enhancing effect on high-intensity exercise. The aim of this study was to investigate the effects of continuous sodium bicarbonate (NaHCO3) supplementation on anaerobic performance during six weeks of high-intensity interval training (HIIT).Entities:
Keywords: Anaerobic performance; High-intensity interval training; Sodium bicarbonate
Mesh:
Substances:
Year: 2019 PMID: 30987663 PMCID: PMC6466775 DOI: 10.1186/s12970-019-0285-8
Source DB: PubMed Journal: J Int Soc Sports Nutr ISSN: 1550-2783 Impact factor: 5.150
Subjects characteristics for two groups*
| Group | Age (yr) | Height (cm) | Weight (kg) | BMI (kg/m2) | Lean Mass (%) | Body Fat (%) | MAP (W) |
|---|---|---|---|---|---|---|---|
| SB | 20.35 ± 0.44 | 1.77 ± 0.05 | 71.52 ± 5.20 | 22.83 ± 1.65 | 46.05 ± 2.20 | 16.95 ± 4.21 | 183.55 ± 35.65 |
| PL | 20.51 ± 0.21 | 1.76 ± 0.05 | 69.57 ± 6.18 | 22.51 ± 1.64 | 45.15 ± 1.90 | 14.98 ± 3.80 | 179.67 ± 25.97 |
Values are means ± SD. SB=HCO3− group, PL= placebo group
*There was not significant difference between two groups on these values
Serum HCO3− level before and after HIIT in the pre-, mid- and post-intervention
| Group | Pre-intervention | Mid-intervention | Post-intervention | |||
|---|---|---|---|---|---|---|
| Before HIIT | After HIIT | Before HIIT | After HIIT | Before HIIT | After HIIT | |
| SB | 25.00 ± 1.06 | 23.62 ± 1.07 | 27.74 ± 1.04 | 25.72 ± 0.83 | 28.49 ± 0.87 | 26.15 ± 0.73 |
| PL | 21.63 ± 0.98 | 20.30 ± 0.58 | 21.31 ± 1.16 | 19.99 ± 0.99 | 21.48 ± 1.18 | 20.55 ± 1.24 |
Values are means ± SD. SB=HCO3− group, PL= placebo group
**indicates a significant difference vs. pre-intervention (p < 0.05)
△indicates a significant difference from mid- to post-intervention (p < 0.05)
†indicates a significant difference (p < 0.05) vs. PL-group
Fig. 1Relative peak power in the pre-, mid- and post-intervention. SB=HCO3− group, PL = placebo group. △△ indicates a significant difference from mid- to post-intervention (p < 0.01). ** indicates a significant difference from pre- to mid-interventin or from pre- to post-intervention (p < 0.01). †† indicates a significant difference (p < 0.01) vs. PL-group
WAnT related indexes data in the pre-, mid- and post-intervention
| Variable | Group | Pre-intervention | Mid-intervention | Post-intervention |
|---|---|---|---|---|
| Relative peak power (W/kg) | SB | 10.58 ± 0.69 | 11.38 ± 0.40** | 12.78 ± 0.68**△△†† |
| PL | 10.05 ± 0.38 | 10.85 ± 0.37** | 11.09 ± 0.47** | |
| Relative mean power (W/kg) | SB | 7.53 ± 0.59 | 8.72 ± 0.43** | 9.17 ± 0.40** |
| PL | 6.96 ± 0.21 | 7.77 ± 0.59** | 8.25 ± 0.74** | |
| Fatigue index % | SB | 55.78 ± 9.24 | 48.95 ± 6.81* | 44.06 ± 6.71** |
| PL | 60.57 ± 12.50 | 55.89 ± 12.11 | 53.10 ± 10.66* | |
| Resting LA (mmol/L) | SB | 1.92 ± 0.64 | 2.00 ± 1.03 | 1.89 ± 0.55 |
| PL | 2.09 ± 0.65 | 2.17 ± 0.74 | 1.59 ± 0.58 | |
| LAmax (mmol/L) | SB | 13.85 ± 1.40 | 15.71 ± 1.25 | 16.44 ± 1.06** |
| PL | 14.83 ± 2.49 | 14.69 ± 2.10 | 14.62 ± 2.06 | |
| LA after (10 min) WAnT (mmol/L) | SB | 12.39 ± 2.14 | 13.43 ± 1.24 | 13.02 ± 1.65 |
| PL | 13.52 ± 2.42 | 12.78 ± 1.72 | 12.45 ± 1.68 | |
| V10 (mmol·L− 1·min− 1) | SB | 0.24 ± 0.08 | 0.49 ± 0.12** | 0.62 ± 0.10**△△†† |
| PL | 0.23 ± 0.07 | 0.39 ± 0.13* | 0.43 ± 0.12** | |
| LA10% | SB | 11.58 ± 1.41 | 16.16 ± 3.01** | 20.40 ± 1.81**△△†† |
| PL | 10.59 ± 2.72 | 14.36 ± 2.26** | 16.00 ± 2.07** | |
| HRR10% | SB | 65.38 ± 5.32 | 75.07 ± 10.20* | 80.54 ± 4.98**△ |
| PL | 63.5 ± 9.35 | 68.39 ± 8.77* | 73.33 ± 8.19* |
Values are means ± SD. LA= lactic acid, LAmax= maximal lactic acid, WAnT= Wingate anaerobic test, SB= HCO3− group, PL= placebo group. (p < 0.05)
△indicates a significant difference from mid- to post-intervention (p < 0.05)
△△indicates a significant difference from mid- to post-intervention (p < 0.01)
*indicates a significant difference from pre- to mid-intervention or from pre- to post-intervention (p < 0.05)
**indicates a significant difference from pre- to mid-intervention or from pre- to post-intervention (p < 0.01)
††indicates a significant difference (p < 0.01) vs. PL-group
Fig. 2a, b LA clearance velocity and LA clearance rate (%) in the pre-, mid- and post-intervention. SB=HCO3− group, PL= placebo group